Rectal cancer management during the COVID-19 pandemic (ReCaP): multicentre prospective observational study.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 33961013.
- Also identified by DOI 10.1093/bjs/znab129 and PMC identifier 8136009.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Concerns over unacceptable high mortality in patients with rectal cancer undergoing surgery or systemic therapy who contract COVID-19 have led to widespread adoption of alternative treatment strategies.The ReCaP study aimed to study these variations and associated outcomes.
Medical subject headings
- COVID-19
- Pandemics
- Quarantine
- Rectal Neoplasms
- Time-to-Treatment